Skip to main content
. 2013 Jan 23;11(1):266–273. doi: 10.3390/md11010266

Figure 3.

Figure 3

Inhibited proliferation of BEPTII and BEPTII-1-treated PC-3 cells. (A) PC-3 cells were treated with 5, 10, 15, 20, 25 and 30 mg/mL BEPTII. (B) PC-3 cells were treated with 5, 10, 15, 20, 25 and 30 mg/mL BEPTII-1. Cell proliferation was measured using MTT at 24, 48, and 72 h after BEPTII and BEPTII-1treatment. Results are expressed as mean±SD. Each experiment was performed in triplicate (n=3).